TY - JOUR T1 - Self-reported taste and smell disorders in patients with COVID-19:distinct features in China JF - medRxiv DO - 10.1101/2020.06.12.20128298 SP - 2020.06.12.20128298 AU - Jia Song AU - Yi-ke Deng AU - Hai Wang AU - Zhi-Chao Wang AU - Bo Liao AU - Jin Ma AU - Chao He AU - Li Pan AU - Yang Liu AU - Isam Alobid AU - De-Yun Wang AU - Ming Zeng AU - Joaquim Mullol AU - Zheng Liu Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/06/15/2020.06.12.20128298.abstract N2 - Objectives We aimed to explore the frequencies of nasal symptoms in patients with COVID-19, including loss of smell and taste, as well as their presentation as the first symptom of the disease and their association with the severity of COVID-19.Methods In this retrospective study, 1,206 laboratory-confirmed COVID-19 patients were included and followed-up by telephone call one month after discharged from Tongji Hospital, Wuhan. Demographic data, laboratory values, comorbidities, symptoms, and numerical rating scale scores (0-10) of nasal symptoms were extracted from the hospital medical records, and confirmed or reevaluated by the telephone follow-up.Results From COVID-19 patients (N = 1,172) completing follow-up, 199 (17%) subjects had severe COVID-19 and 342 (29.2%) reported nasal symptoms. The most common nasal symptom was loss of taste (20.6%, median score = 6), while 11.4% had loss of smell (median score = 5). The incidence of nasal symptom including loss of smell and loss of taste as the first onset symptom was <1% in COVID-19 patients. Loss of smell or taste scores showed no correlation with the scores of other nasal symptoms. Loss of taste scores, but not loss of smell scores, were significantly increased in severe vs. non-severe COVID-19 patients. Interleukin (IL)-6 and lactose dehydrogenase (LDH) serum levels positively correlated with loss of taste scores. About 80% of COVID-19 patients recovered from smell and taste dysfunction in 2 weeks.Conclusion In the Wuhan COVID-19 cohort, only 1 out of 10 hospital admitted patients had loss of smell while 1 out 5 reported loss of taste which was associated to severity of COVID-19. Most patients recovered smell and taste dysfunctions in 2 weeks.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was supported by Natural Science Foundation of Hubei Province of China grant [2018CFB602 (M.Z.)], National Key R&D Program of China (2018YFC0116800), and National Natural Science Foundation of China (NSFC) grants [81630024 and 81920108011 (Z.L.), and 81900925 (J.S.)].Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study was approved by the ethics committee of Tongji Hospital and informed consent was obtained from each subject.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesStatement by the authors: all data in the manuscript and note links below is available. https://pan.baidu.com/s/1GeBjkdG1ExzdQIeqk3XvPg ER -